Sacubitril/valsartan is well tolerated in patients with heart failure and a history of cancer
5 December 2019 (14:00 - 18:00)
Organised by:
4 More presentations in this session
Access the full session
The Event
EuroEcho 2019
5 December 2019
14:00 CET
